In thisstudy, we demonstrated that both EGFR mRNA and its promoter activity were inhibitedby HDAC inhibitors in colon cancer cells, indicating that the denovo synthesis of EGFR was transcriptionally inhibited. This evidence concerns the gene EGFR and colonic neoplasm.